期刊文献+

复发性卵巢癌治疗新进展 被引量:14

下载PDF
导出
摘要 卵巢癌是妇科肿瘤中死亡率居首位的肿瘤,传统的治疗方法为肿瘤细胞减灭术的基础上联合药物(铂类和紫杉醇为主的)化疗,近年治疗方法的进步使越来越多的患者得到完全缓解,但最终大多患者会复发。复发后存活时间一般少于3年。复发性卵巢癌主要的治疗方法仍是化疗(铂敏感型仍采用铂类为基础的化疗,铂耐药型则多认为使用非铂类药物)和手术(二次肿瘤细胞减灭术)。以肿瘤发病机制为基础的靶向治疗方法近年成为研究热点,进一步研究基因和信号转导途径将为治疗该病提供新途径。现就近年各种治疗方法的有效性和安全性做一综述。
出处 《现代妇产科进展》 CSCD 2012年第1期64-66,69,共4页 Progress in Obstetrics and Gynecology
基金 上海市教委重点学科项目 上海市妇科肿瘤重点实验室项目
  • 相关文献

参考文献22

  • 1沈铿.复发性卵巢癌的诊断和治疗策略[J].现代妇产科进展,2005,14(3):177-180. 被引量:34
  • 2Rustin GJ,vander Burg ME,Griffin CL,et al.Early versusdelayed treatment of relapsed ovarian cancer(MRCOV05/EORTC 55955):a randomised trial.[J]Lancet,2010,376(9747):1155-1163.
  • 3Fleming ND,Cass I,Walsh CS,et al.CA125 surveillanceincreases optimal resectability at secondary cytoreductivesurgery for recurrent epithelial ovarian cancer[J].GynecolOncol,2011,121(2):249-252.
  • 4Galaal K,Naik R,Bristow RE,et al.Cytoreductive surgeryplus chemotherapy versus chemotherapy alone for recur-rent epithelial ovarian cancer[J].Cochrane Database SystRev,2010,16(6):CD007822.
  • 5Chi DS,McCaughty K,Diaz JP,et al.Guidelines and se-lection criteria for secondary cytoreductive surgery in pa-tients with recurrent,platinum-sensitive epithelial ovariancarcinoma[J].Cancer,2006,106(9):1933-1939.
  • 6Alberts DS,Liu PY,Wilczynski SP,et al.Randomized trialof pegylated liposomal doxorubicin(PLD)plus carbopla-tin versus carboplatin in platinum-sensitive(PS)patientswith recurrent epithelial ovarian or peritoneal carcinomaafter failure of initial platinum-based chemotherapy(Southwest Oncology Group Protocol S0200)[J].GynecolOncol,2008,108(1):90-94.
  • 7Bookman MA,Brady MF,McGuire WP,et al.Evaluation ofnew platinum-based treatment regimens in advanced-stageovarian cancer:a phaseⅢtrial of the Gynecologic CancerIntergroup[J].J Clin Oncol,2009,27:1419-1425.
  • 8Verhaar-Langereis M,Karakus A,Van Eijkeren M,et al.PhaseⅡstudy of the combination of pegylated liposomaldoxorubicin and topotecan in platinum-resistant ovariancancer[J].Inter J Gynecol Cancer,2006,16(1):65-70.
  • 9Leffers N,Daemen T,Helfrich W,et al.Antigen-specificactive immunotherapy for ovarian cancer[J].CochraneDatabase Syst Rev,2010,(1):CD007287.
  • 10Leffers N,Vermeij R,Hoogeboom BN,et al.Long-termclinical and immunological effects of p53-SLP vaccine inpatients with ovarian cancer[J].Int J Cancer,2011,doi:10.1002/ijc.25980.

共引文献33

同被引文献133

引证文献14

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部